The IDIC Epidemic (Star Trek, Book 38)
Description:
The Idic Epidemic
I.D.I.C -- Infinite Diversity in Infinite Combination. More than just a simple credo, for those of the planet Vulcan it is the cornerstone of their philosophy.
Now, on the Vulcan Science Colony Nisus, that credo of tolerance is being being put to its sternest test. For here, on a planet where Vulcan, human, Klingon, and countless other races live and work side by side, a deadly plague whose origins has sprung up. Aplague whose origins are somehow rooted in the concept of I.D.I.C. itself. A plague that threatens to tear down that centuries-old maxim and replace it with an even older concept.
Intersellar War
Best prices to buy, sell, or rent ISBN 9780671635749
Related Books
- 1
- 2
- 3
- Idic Epidemic #38ISBN-13:9780785747277
- The IDIC Epidemic (Classic Star Trek, No. 38)Jean LorrahISBN-13:9780671707682
- The IDIC Epidemic (Star Trek: The Original Series, #38)Jean LorrahISBN-13:9780743419895
- Idic Epidemic #38ISBN-13:9780785747277
- The IDIC Epidemic (Classic Star Trek, No. 38)Jean LorrahISBN-13:9780671707682
Frequently Asked Questions about The IDIC Epidemic (Star Trek, Book 38)
The price for the book starts from $5.96 on Amazon and is available from 39 sellers at the moment.
At BookScouter, the prices for the book start at $0.98. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the The IDIC Epidemic (Star Trek, Book 38) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The IDIC Epidemic (Star Trek, Book 38) book, the best buyback offer comes from and is $ for the book in good condition.
The The IDIC Epidemic (Star Trek, Book 38) book is in very low demand now as the rank for the book is 2,639,003 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.